2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Lymphocyte Count: new trials by email Literature Review of Lymphocyte Count trials Research Report on Lymphocyte Count
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer Natural Killer (NK) Lymphocytes, IL-2, Cyclophosphamide - Metastatic Melanoma, Metastatic Kidney Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 8 | 2006-05-01 | 2012-11-05 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia aldesleukin, therapeutic allogeneic lymphocytes, cyclophosphamide - Leukemia | Phase 2 | Completed | Masonic Cancer Center, University of Minnesota | 21 | 2005-03-01 | 2017-12-28 |
Congenital Abnormalities (1) · Kidney Neoplasms (1) · Leukemia (1) · Leukemia, Myeloid, Acute (1) · Melanoma (1)
Masonic Cancer Center, University of Minnesota (1) · National Cancer Institute (NCI) (1)
United States (2)